Moreover, MEOX1 has been found to be upregulated in non-small cell lung cancer (NSCLC) and is positively associated with lymph node metastasis, advanced clinical staging, and unfavorable survival in NSCLC patients; In vitro studies have also shown that upregulation of MEOX1 enhances cell proliferation and colony-forming abilities [18]. Here, MEOX1 is linked to non-small cell lung carcinoma.